Kidney Cancer

>

Latest News

A minimally invasive cryoablation technology system designed to treat patients with kidney tumors and elicit an 89.65% recurrence-free rate.
Cryoablation Approach Linked to Shorter Hospitalizations, High Recurrence-Free Rate for Kidney Cancer

June 20th 2024

A minimally invasive cryoablation technology system designed to treat patients with kidney tumors and elicit an 89.65% recurrence-free rate.

Delays in All Organ Tumor Progression Observed in Lenvatinib/Pembrolizumab in Advanced RCC
Delays in All Organ Tumor Progression Observed in Lenvatinib/Pembrolizumab in Advanced RCC

June 5th 2024

Pre-Treatment TILs Does Not Impact Nivolumab/Ipilimumab Therapy in mccRCC
Pre-Treatment TILs Does Not Impact Nivolumab/Ipilimumab Therapy in mccRCC

June 2nd 2024

Treatment with DFF332 appears to be safe and tolerable across all dose levels, according to Sumanta Kumar Pal, MD.
DFF332 Shows Potential Activity in Advanced Clear Cell RCC

June 1st 2024

Learning AE Management With Immunotherapy vs TKIs in RCC
Learning AE Management With Immunotherapy vs TKIs in RCC

May 22nd 2024

More News